In this paper, by employing an eco-friendly and green approach, semiconductor CuO/ZnO nanocomposite are synthesized using an aqueous extract of Urtica urens. FT-IR, XRD, TEM, SAED, EDX, TGA, and UV-Vis spectroscopy were used for semiconductor characterization. The data revealed the successful formation of crystalline spherical nanocomposites with sizes ranging from 5 to 45 nm. The main components of the synthesized nanocomposites were Cu, Zn, and O, which had different weights and atomic percentages. The maximum absorbance of nanocomposites was 358 nm, with a direct bandgap of 2.25 eV, which is suitable for photocatalysis under visible light. The maximum photocatalytic activity of the synthesized semiconductor nanocomposites for photodegradation of methylene blue dye was 95.8%, where it was 44.5% and 65.5% for monometallic CuO and ZnO, respectively. The optimum conditions for maximum photocatalytic activity were a pH of 9, a dye concentration of 5 mg L⁻¹, and nanocomposite concentration of 1.0 mg mL⁻¹ after 70 min. The reusability of the synthesized semiconductor was promising for the fourth cycle, with a reduced capacity of 5%. Complementary investigations, antimicrobial activity and cytotoxic activity, were performed to increase the application of semiconductor nanocomposites. The data revealed the promising activity of the nanocomposite against E. coli, P. aeruginosa, B. subtilis, S. aureus, C. parapsilosis, C. albicans, and C. tropicalis with low MICs ranging between 50 and 25 µg mL⁻¹. Additionally, compared with normal cell line, the synthesized nanocomposite targeted the cancer cell line HepG2 with a low IC50 value of 69.9 µg mL⁻¹ (vs. IC50 220 µg mL⁻¹ of normal cell line HFB4). Overall, the green-synthesized semiconductor CuO/ZnO nanocomposite showed promising activity as environmental contaminant cleaner and was integrated with antimicrobial and in vitro cytotoxic activities.

Anastatica hierochuntica L. (Cruciferae) has been known in Egyptian folk medicine as a remedy for gastrointestinal disorders, diabetes and heart diseases. Despite the wide usage, A. hierochuntica research provides insufficient data to support its traditional practice. The cytotoxicity of A. hierochuntica methanolic extract was investigated on acute myeloid leukemia blasts (AML) and normal human peripheral leucocytes (NHPL). The phytochemical identification of bioactive compounds using ¹H-NMR and LC-ESI-MS was also performed. A. hierochuntica extract caused non-significant cytotoxicity on NHPL, while the cytotoxicity on AML was significant (IC₅₀: 0.38 ± 0.02 μg/mL). The negative expression of p53, upregulation of Caspase-3 and increase in the BAX/BCL-2 ratio were reported at the protein and mRNA levels. The results suggest that A. hierochuntica extract induced AML cell death via the p53-independent mitochondrial intrinsic pathway and further attention should be paid to this plant as a promising natural anticancer agent.

The journal Metabolites retracts the article “In Vitro Induction of Apoptosis in Isolated Acute Myeloid Leukemia Cells: The Role of Anastatica hierochuntica Methanolic Extract”